Literature DB >> 25037254

Stevens-Johnson syndrome and toxic epidermal necrolysis: clinical patterns, diagnostic considerations, etiology, and therapeutic management.

Maja Mockenhaupt1.   

Abstract

Severe cutaneous adverse reactions are associated with significant morbidity and mortality. They may be life-threatening for the affected patient and difficult to treat. Such conditions include toxic epidermal necrolysis (TEN), Stevens-Johnson syndrome (SJS), acute generalized exanthematous pustulosis and drug reaction with eosinophilia and systemic symptoms. Due to the fact that prognosis, etiology and treatment of the various reactions differ, a clear diagnosis based on the specific clinical pattern is important. This review will focus on the clinical presentations, pathogenesis, and important diagnostic and therapeutic considerations in the management of SJS and TEN.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25037254     DOI: 10.12788/j.sder.0058

Source DB:  PubMed          Journal:  Semin Cutan Med Surg        ISSN: 1085-5629


  16 in total

Review 1.  The 9th International Congress on Cutaneous Adverse Drug Reactions at the 23rd World Congress of Dermatology in Vancouver, 2015.

Authors:  Roni P Dodiuk-Gad; Cristina Olteanu; Wen-Hung Chung; Neil H Shear
Journal:  Drug Saf       Date:  2016-03       Impact factor: 5.606

Review 2.  Treatments for Severe Cutaneous Adverse Reactions.

Authors:  Yung-Tsu Cho; Chia-Yu Chu
Journal:  J Immunol Res       Date:  2017-12-27       Impact factor: 4.818

3.  Management of Toxic Epidermal Necrolysis with Plasmapheresis and Cyclosporine A: Our 10 Years' Experience.

Authors:  Giuseppe Giudice; Giulio Maggio; Loredana Bufano; Giuseppe Memeo; Michelangelo Vestita
Journal:  Plast Reconstr Surg Glob Open       Date:  2017-02-22

Review 4.  Severe Delayed Drug Reactions: Role of Genetics and Viral Infections.

Authors:  Rebecca Pavlos; Katie D White; Celestine Wanjalla; Simon A Mallal; Elizabeth J Phillips
Journal:  Immunol Allergy Clin North Am       Date:  2017-11       Impact factor: 3.479

5.  The severe complication of Stevens-Johnson syndrome induced by long-term clozapine treatment in a male schizophrenia patient: a case report.

Authors:  Ming-Kung Wu; Weilun Chung; Ching-Kuan Wu; Ping-Tao Tseng
Journal:  Neuropsychiatr Dis Treat       Date:  2015-04-09       Impact factor: 2.570

6.  Ibuprofen induced Stevens-Johnson syndrome - toxic epidermal necrolysis in Nepal.

Authors:  Siddheshwar S Angadi; Abhishek Karn
Journal:  Asia Pac Allergy       Date:  2016-01-27

7.  HLA Allele Frequencies in 5802 Koreans: Varied Allele Types Associated with SJS/TEN According to Culprit Drugs.

Authors:  Hye Jung Park; Young Joo Kim; Dong Hyun Kim; Junho Kim; Kyung Hee Park; Jung Won Park; Jae Hyun Lee
Journal:  Yonsei Med J       Date:  2016-01       Impact factor: 2.759

8.  Association of the HLA-B alleles with carbamazepine-induced Stevens-Johnson syndrome/toxic epidermal necrolysis in the Javanese and Sundanese population of Indonesia: the important role of the HLA-B75 serotype.

Authors:  Rika Yuliwulandari; Erna Kristin; Kinasih Prayuni; Qomariyah Sachrowardi; Franciscus D Suyatna; Sri Linuwih Menaldi; Nuanjun Wichukchinda; Surakameth Mahasirimongkol; Larisa H Cavallari
Journal:  Pharmacogenomics       Date:  2017-10-20       Impact factor: 2.533

Review 9.  Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis: A Concise Review with a Comprehensive Summary of Therapeutic Interventions Emphasizing Supportive Measures.

Authors:  Jeremy A Schneider; Philip R Cohen
Journal:  Adv Ther       Date:  2017-04-24       Impact factor: 3.845

10.  The Epidemiology of Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis in China.

Authors:  Shang-Chen Yang; Sindy Hu; Sheng-Zheng Zhang; Jin-Wen Huang; Jing Zhang; Chao Ji; Bo Cheng
Journal:  J Immunol Res       Date:  2018-02-11       Impact factor: 4.818

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.